You are here » Home » Companies » Company Overview » Glenmark Pharmaceuticals Ltd

Glenmark Pharmaceuticals Ltd.

BSE: 532296 Sector: Health care
NSE: GLENMARK ISIN Code: INE935A01035
BSE LIVE 15:41 | 02 Dec 863.05 -13.25
(-1.51%)
OPEN

873.65

HIGH

876.30

LOW

860.75

NSE LIVE 15:56 | 02 Dec 861.85 -14.55
(-1.66%)
OPEN

876.55

HIGH

876.60

LOW

859.30

OPEN 873.65
PREVIOUS CLOSE 876.30
VOLUME 22170
52-Week high 993.00
52-Week low 671.50
P/E 31.66
Mkt Cap.(Rs cr) 24355.27
Buy Price 0.00
Buy Qty 0.00
Sell Price 863.05
Sell Qty 10.00
OPEN 873.65
CLOSE 876.30
VOLUME 22170
52-Week high 993.00
52-Week low 671.50
P/E 31.66
Mkt Cap.(Rs cr) 24355.27
Buy Price 0.00
Buy Qty 0.00
Sell Price 863.05
Sell Qty 10.00

About Glenmark Pharmaceuticals Ltd.

Glenmark Pharmaceuticals Ltd

Glenmark Pharmaceuticals Ltd - Key Fundamentals

Parameter Values
Market Cap ( cr)   24,355
EPS - TTM () [*C] 27.26
P/E Ratio (X) [*C] 31.66
Face Value ()   1
Latest Dividend (%)   200.00
Latest Dividend Date 03 Aug 2016
Dividend Yield (%) 0.23
Book Value / Share () [*C] 145.16
P/B Ratio () [*C] 5.95
[*C] Consolidated     [*S] Standalone

Glenmark Pharmaceuticals Ltd - Financial Results

Particulars ( cr) Sep 2016 Sep 2015 % Chg
Net Sales 2224.11 1909.36 16.48
Other Income -1.84 0.8 -330
Total Income 2222.27 1910.16 16.34
Total Expenses 1775.34 1505.6 17.92
Operating Profit 446.93 404.56 10.47
Net Profit 223.59 216.07 3.48
Equity Capital 28.22 28.22 -
> More on Glenmark Pharmaceuticals Ltd Financials Results

Glenmark Pharmaceuticals Ltd - Peer Group

Company Price() Chg (%) Mkt Cap ( CR)
Cadila Health. 395.25 -1.09 40461.74
Divi's Lab. 1135.30 -1.19 30136.54
Piramal Enterp. 1638.05 0.14 28264.55
Glenmark Pharma. 863.05 -1.51 24355.27
Glaxosmit Pharma 2715.30 1.01 22998.59
Torrent Pharma. 1347.85 -2.97 22808.32
Alkem Lab 1681.25 0.51 20099.34
> More on Glenmark Pharmaceuticals Ltd Peer Group

Glenmark Pharmaceuticals Ltd - SHAREHOLDING PATTERN

Category Share (%)
Promoters 46.49
Banks/FIs 3.66
FIIs 35.64
Insurance 0.00
Mutual Funds 2.28
Indian Public 8.38
Custodians 0.00
Other 3.53
> More on Glenmark Pharmaceuticals Ltd Share Holding Pattern

Glenmark Pharmaceuticals Ltd - Research Reports

Date Broker Action Price Report
22/07 Prabhudas Lilladher Buy 865 PDF IconDetails
15/05 Prabhudas Lilladher Buy 869 PDF IconDetails
13/05 Motilal Oswal Neutral 869 PDF IconDetails
29/01 Prabhudas Lilladher Buy 771 PDF IconDetails
31/10 Motilal Oswal Neutral 992 PDF IconDetails
> More on Glenmark Pharmaceuticals Ltd Research Reports

Glenmark Pharmaceuticals Ltd - RETURNS

Period BSE NSE Sensex NIFTY
1 Week -4.68% -4.93% -0.33% -0.34%
1 Month -8.26% -5.56% -4.71% -4.69%
3 Month 2.91% 2.77% -8.07% -8.21%
6 Month 3.31% 6.41% -2.28% -1.63%
1 Year -11.79% -10.04% 0.43% 2.83%
3 Year 65.34% 65.68% 25.52% 30.39%

Glenmark Pharmaceuticals Ltd - STOCK STRENGTH

Today's Low/High 860.75
876.30
Week Low/High 860.75
916.00
Month Low/High 806.00
962.00
YEAR Low/High 671.50
993.00
All TIME Low/High 1.89
1262.00

Upgrade To Premium Services

Welcome User

Business Standard is happy to inform you of the launch of "Business Standard Premium Services"

As a premium subscriber you get an across device unfettered access to a range of services which include:

  • Access Exclusive content - articles, features & opinion pieces
  • Weekly Industry/Genre specific newsletters - Choose multiple industries/genres
  • Access to 17 plus years of content archives
  • Set Stock price alerts for your portfolio and watch list and get them delivered to your e-mail box
  • End of day news alerts on 5 companies (via email)
  • NEW: Get seamless access to WSJ.com at a great price. No additional sign-up required.
 

Premium Services

In Partnership with

 

Dear Guest,

 

Welcome to the premium services of Business Standard brought to you courtesy FIS.
Kindly visit the Manage my subscription page to discover the benefits of this programme.

Enjoy Reading!
Team Business Standard